Spinal Muscular Atrophy
1 competing product in clinical development for Spinal Muscular Atrophy.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Placebo + Reldesemtiv 150 mg + Reldesemtiv 450 mg | Astellas Pharma | Phase 2 | Completed | 35 |